肌少症对头颈癌手术老年患者术后并发症与住院时长的影响
这项前瞻性队列研究纳入251例50岁及以上接受头颈癌大手术的患者,用颈部肌肉影像、握力和计时行走判定肌少症。结果显示肌少症与更长住院时间和更差总生存相关,提示其可用于术前风险预测。
要点
- 肌少症患者术后住院时间更长(β=0.32,95%CI 0.19-0.45)。
- 肌少症与更差总生存相关(HR=2.21,95%CI 1.01-4.23)。
- 术前识别肌少症有助于预测头颈癌大手术风险。
核心结论
- 肌少症可能有助于预测头颈癌大手术候选患者的住院时间延长和死亡。
研究设计与样本
- 前瞻性队列研究,纳入251例50岁及以上接受头颈癌大手术的患者。
- 肌少症定义为低肌肉量(颈部肌肉横断面影像)合并低肌力(握力)或低肌肉表现(计时行走测试)。
主要发现
- 251例中癌前肌少症占34.9%(n=87),肌少症占15.6%(n=39)。
- 肌少症患者更可能年龄更大(P=.001)、女性(P=.001)、BMI更低(P=.001)及术前血红蛋白更低(P<.001)。
- 单因素分析中肌少症的存在与严重程度与内科并发症(P=.029)、更高并发症分级(P=.032)、住院时间(P=.015)和总生存(P=.001)相关。
- 多因素分析中肌少症与更长住院时间(β=0.32,95%CI 0.19-0.45,P<.001)和更差总生存(HR=2.21,95%CI 1.01-4.23,P=.017)相关。
临床怎么用
- 对接受头颈癌大手术的老年患者,术前可评估肌少症以辅助预测住院时间延长和死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES/HYPOTHESIS: Sarcopenia is a hallmark of aging and its identification may help predict adverse postoperative events in patients undergoing head and neck surgery. The study objective was to assess the relationship between sarcopenia and postoperative complications and length of stay in patients undergoing major head and neck cancer surgery. STUDY DESIGN: Prospective cohort study. METHODS: A prospective cohort study was performed of patients 50 years and older undergoing major head and neck surgery. Sarcopenia was defined as low muscle mass (determined by neck muscle cross-sectional imaging) with either low muscle strength (grip strength) or low muscle performance (timed walk test). Logistic regression was applied on binary outcomes, and linear regression was used for log-transformed length of hospital stay (LOS). Univariate and multivariate analyses were performed. RESULTS: Of the 251 patients enrolled, pre-sarcopenia was present in 34.9% (n = 87) and sarcopenia in 15.6% (n = 39) of patients. Patients with sarcopenia were more likely to be older (P = .001), female (P = .001), have a lower body mass index (P = .001), and lower preoperative hemoglobin (P < .001). On univariate analysis, the presence and severity of sarcopenia was associated with the development of medical complications (P = .029), higher grade of complications (P = .032), LOS (P = .015), and overall survival (P = .001). On multivariate analysis, sarcopenia was associated with a longer LOS (β = 0.32 [95% CI: 0.19-0.45], P < .001) and worse overall survival (HR = 2.21 [95% CI: 1.01-4.23], P = .017). CONCLUSIONS: Sarcopenia may aid in the prediction of prolonged hospital stay and death in patients who are candidates for major head and neck surgery. LEVEL OF EVIDENCE: 3 Laryngoscope, 132:356-363, 2022.
引用
- Orzell S, Verhaaren BFJ, Grewal R, et al. Evaluation of Sarcopenia in Older Patients Undergoing Head and Neck Cancer Surgery. Laryngoscope. 2021. PMID: 34383321. doi:10.1002/lary.29782
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。